Wogonin attenuates diabetic cardiomyopathy through its anti-inflammatory and anti-oxidative properties

Area of Science:

• Biochemistry
• Pharmacology
• Cardiology

Background:

• Diabetic cardiomyopathy is a major cardiovascular complication of diabetes, often leading to cardiac failure.
• Wogonin, derived from Scutellaria baicalensis, possesses known anti-diabetic properties, but its impact on diabetic cardiomyopathy is not well understood.

Purpose of the Study:

• To investigate the potential protective effects of wogonin on diabetic cardiomyopathy.
• To elucidate the underlying mechanisms by which wogonin may exert its effects.

Main Methods:

• Streptozotocin (STZ)-induced diabetic mice model was used to evaluate wogonin's efficacy.
• Cardiac function, fibrosis, cardiomyocyte apoptosis, oxidative stress markers (ROS, MDA), and inflammatory factors (IL-1β, IL-6, TNFα, PAI-1) were assessed.
• The NF-κB signaling pathway was investigated.

Main Results:

• Wogonin administration significantly suppressed hyperglycemia and improved cardiac function in diabetic mice.
• Wogonin treatment mitigated cardiac fibrosis, cardiomyocyte apoptosis, and necrosis.
• Wogonin demonstrated anti-oxidative stress and anti-inflammatory effects by enhancing antioxidant enzyme activity, reducing oxidative stress markers, and suppressing inflammatory signaling pathways, including NF-κB.

Conclusions:

• Wogonin shows potential in mitigating hyperglycemia-related cardiomyocyte impairment in diabetic cardiomyopathy.
• The protective mechanisms involve the inhibition of inflammation and oxidative stress.